2021, Vol. 5 Issue 2, Part CPages: 180-187
A clinical study on ziabetus shakri qism doem (Diabetes mellitus type 2) and its management with Unani formulation, A randomized standard controlled study
Dr. Majid Ali Ansari and Rais-Ur-Rahman
Viewed: 439 - Downloaded: 131
The word “Diabetes” is derived from the Greek word “Diabanmo”, which means passing through or to run through or siphon. According to Unani literature retrieved from Al Qaanon, Al Hawi, Kamilus Sanaah, diabetes mellitus is called Ziabetus Sakri. The description of ziabetus (Diabetes) in Unani classical literature is available since the time of Hippocrates and Ziabetus was considered as a disease of the kidneys. Arabian physicians have also described Ziabetus by the terms: Moattasha/Atsha, Zalaqul kulliya, Dolab, Dawwarah, Barkar/Barkarya, and Qaramees. Type 2 Diabetes Mellitus is a heterogeneous group of disorders characterized by variable degree of insulin resistance, impaired insulin secretion and excessive hepatic glucose production. Common presenting symptoms of Diabetes Mellitus include polyuria, polydipsia, polyphagia, weight loss, fatigue, weakness, blurred vision, frequent superficial infections and poor wound healing. The chronic hyperglycemia of diabetes is associated with long term complications, dysfunction and failure of various organs, especially the eyes, kidneys, nerves, heart and blood vessels. In conventional system of medicine several classes of drugs are being used to manage Type 2 Diabetes Mellitus, but apart from being effective, most of these drugs have drastic side effects on several organs and body functions, hence, their long term use is not in favour of the wellbeing of the Diabetic patient. In order to overcome the problem of the unwanted effects of the modern drugs, a clinical study with a Unani polyherbal formulation containing Shoneez (Nigella Sativa), Darchini (Cinnamon zeylanicum), Hulba (Trigonella foenum graceum) and Maghz Tukhm-e-Jamun (Syzygium Cuminum) for the management of Diabetes Mellitus Type 2 has been undertaken. At the end of the study the test drug was found efficacious and safe in the treatment of Type 2 Diabetes Mellitus.